TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 18779029

Group type: EXPERIMENTAL
Intervention: Group-based DPP lifestyle intervention by the YMCA
Number of subjects: 92

Group type: COMPARATOR
Intervention: Brief counseling alone (control)
Number of subjects: 92
Study: 16736081

Group type: COMPARATOR
Intervention: Neutral birthday greeting
Number of subjects: 994

Group type: EXPERIMENTAL
Intervention: Harm reduction information
Number of subjects: 994

Group type: EXPERIMENTAL
Intervention: Messages from the B.R.A.D. Foundation
Number of subjects: 994

Group type: EXPERIMENTAL
Intervention: Social norming messages
Number of subjects: 994

Group type: EXPERIMENTAL
Intervention: Combination of harm reduction and social norming messages
Number of subjects: 994
Study: 12880623

Group type: EXPERIMENTAL
Intervention: Child-targeted nutrition counselling for parents over 6.5 years
Number of subjects: 187

Group type: COMPARATOR
Intervention: Control group (no child-targeted nutrition counselling)
Number of subjects: 187
Study: 11494182

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Trager
Number of subjects: 18
Study: 9566274

Group type: EXPERIMENTAL
Intervention: Recombinant IFN alpha 2a
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Recombinant IFN alpha 2b
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Lymphoblastoid IFN alpha
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Leukocyte IFN alpha
Number of subjects: 96

Group type: COMPARATOR
Intervention: Control group (untreated hepatitis C patients)
Number of subjects: 96
Study: 7761019

Group type: EXPERIMENTAL
Intervention: Betamethasone 0.1 mg/kg administered 10 min after continuous infusion of vecuronium
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Vecuronium 0.08 mg/kg bolus followed by continuous infusion of 0.4‐0.5 micrograms/kg/min
Number of subjects: 20
Study: 3288070

Group type: EXPERIMENTAL
Intervention: Aspirin 500 mg tid for seven days
Number of subjects: 51

Group type: COMPARATOR
Intervention: Control (no aspirin)
Number of subjects: 51
Study: 31965579

Group type: EXPERIMENTAL
Intervention: Obeticholic acid (OCA) 25 mg orally once daily
Number of subjects: 78

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Obeticholic acid (OCA)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: MRI-PDFF responders (30% or greater decline)
Number of subjects: 78
Study: 30670515

Group type: EXPERIMENTAL
Intervention: History of 1 miscarriage
Number of subjects: 977

Group type: EXPERIMENTAL
Intervention: History of ≥2 miscarriages
Number of subjects: 977

Group type: COMPARATOR
Intervention: Only live birth
Number of subjects: 977
Study: 27864638

Group type: EXPERIMENTAL
Intervention: Caffeine (4 mg kg‐1)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study: 25277169

Group type: EXPERIMENTAL
Intervention: 30%EMGpeak (34%MVC)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 20%EMGpeak (23%MVC)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: IET (combined for females)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: IET (combined for males)
Number of subjects: 40
Study: 23963274

Group type: EXPERIMENTAL
Intervention: Zinc supplementation (2 mg/kg/day for 60 days)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 38
Study: 21598858

Group type: EXPERIMENTAL
Intervention: Analogy-guided learning activities incorporated into weekly group discussions, reflective journal writing, and questioning with clinical faculty.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional activities (control group).
Number of subjects: 0
Study: 19090531

Group type: EXPERIMENTAL
Intervention: Behavioral therapy (BT) including Individualized Sleep Promotion Plan (ISPP) with modified stimulus control, modified sleep restriction, relaxation therapy, and sleep hygiene.
Number of subjects: 219

Group type: EXPERIMENTAL
Intervention: Behavioral therapy (BT)
Number of subjects: 219

Group type: COMPARATOR
Intervention: Control group receiving healthy eating information and attention.
Number of subjects: 219
Study: 16720830

Group type: EXPERIMENTAL
Intervention: Hematide 0.1 mg/kg
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 15464488

Group type: COMPARATOR
Intervention: Papaverine injection before harvest (Group 2)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Papaverine delivery after dissection (Group 3)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Control group (Group 1)
Number of subjects: 58
Study: 11779325

Group type: EXPERIMENTAL
Intervention: Mastoid obliteration using a temporoparietal fascial flap
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conservative treatment and observation
Number of subjects: 60
Study: 9025770

Group type: EXPERIMENTAL
Intervention: 5-fluorouracil (375 mg/m2 per day) and leucovorin (200 mg/m2 per day) administered intravenously (days 1-5) with levamisole (30 to 470 mg/m2 per day) administered orally (days 1-3 and 15-17)
Number of subjects: 38

Group type: COMPARATOR
Intervention: 5-fluorouracil and leucovorin alone
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: 5-fluorouracil and leucovorin with levamisole
Number of subjects: 38
Study: 8513037

Group type: EXPERIMENTAL
Intervention: Late melatonin (5 mg for 5 days after 3 days of placebo)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Early melatonin (5 mg started 3 days prior to arrival until 5 days after return home)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 31809432

Group type: EXPERIMENTAL
Intervention: Routine pessary care (office visits every 12 weeks)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Extended pessary care (office visits every 24 weeks)
Number of subjects: 130
Study: 30874251

Group type: EXPERIMENTAL
Intervention: Toothpaste containing arginine (ProRelief, Colgate)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Fluoride toothpaste (Pronamel, Sensodyne GlaxoSmithKlein)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Tooth mousse containing casein phosphopeptide‐amorphous calcium phosphate (CPP‐ACP) (Recaldent, GC)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Toothpaste (Restore, Dr. Collins) containing bioactive glass (NovaMin, GlaxoSmithKlein)
Number of subjects: 50

Group type: COMPARATOR
Intervention: No treatment (control)
Number of subjects: 50
Study: 27660924

Group type: EXPERIMENTAL
Intervention: Quiet routine protocol (intervention)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (standard ICU environment)
Number of subjects: 0
Study: 25898217

Group type: EXPERIMENTAL
Intervention: Lifestyle intervention
Number of subjects: 51

Group type: COMPARATOR
Intervention: Financial counseling
Number of subjects: 51
Study: 23722592

Group type: EXPERIMENTAL
Intervention: Recombinant adenoviral human p53 gene therapy (rAd‐p53) with radiotherapy (60 Gy)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Control group (CG) with radiotherapy (60 Gy)
Number of subjects: 107
Study: 21775930

Group type: EXPERIMENTAL
Intervention: sirolimus‐MMF
Number of subjects: 122

Group type: COMPARATOR
Intervention: tacrolimus‐MMF
Number of subjects: 122
Study: 18323730

Group type: EXPERIMENTAL
Intervention: Postpartum breast-feeding support by nurses (telephone calls once a week for 4 weeks postpartum, then once a month for 16 weeks postpartum)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Control group (telephone call at postpartum week 4, 8, 12, and 16)
Number of subjects: 55
Study: 16525604

Group type: EXPERIMENTAL
Intervention: Sonic electric toothbrush
Number of subjects: 50

Group type: COMPARATOR
Intervention: Traditional manual toothbrush (control group)
Number of subjects: 50
Study: 12938264

Group type: EXPERIMENTAL
Intervention: 5-FU-based chemotherapy
Number of subjects: 5365

Group type: EXPERIMENTAL
Intervention: gemcitabine
Number of subjects: 5365

Group type: COMPARATOR
Intervention: 5-FU or other cytotoxic agent alone
Number of subjects: 5365

Group type: COMPARATOR
Intervention: various 5-FU combinations
Number of subjects: 5365
Study: 11099446

Group type: EXPERIMENTAL
Intervention: Functional MRI (fMRI) during passive movement task
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Median nerve stimulation of the hemiplegic hand
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Behavioural tests (grip strength, double simultaneous stimulation, joint position sense)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Behavioural tests
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Overall findings
Number of subjects: 17
Study: 8783704

Group type: EXPERIMENTAL
Intervention: Imipenem
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Ampicillin/sulbactam
Number of subjects: 79

Group type: COMPARATOR
Intervention: DIC presence
Number of subjects: 79

Group type: COMPARATOR
Intervention: Inappropriate antimicrobial treatment
Number of subjects: 79

Group type: COMPARATOR
Intervention: Overall mortality
Number of subjects: 79
Study: 1385761

Group type: EXPERIMENTAL
Intervention: Toremifene 200 mg/m2 p.o. daily
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Toremifene 300 mg/m2 p.o. daily
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Toremifene 400 mg/m2 p.o. daily
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Toremifene (all doses)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Toremifene pharmacokinetics
Number of subjects: 19
Study: 6384847

Group type: EXPERIMENTAL
Intervention: Nova T
Number of subjects: 1865

Group type: COMPARATOR
Intervention: Copper T 200
Number of subjects: 1865
Study: 31665933

Group type: EXPERIMENTAL
Intervention: Self-monitoring combined with earning monetary incentives for behavior
Number of subjects: 0

Group type: COMPARATOR
Intervention: Self-monitoring of fruit and vegetable consumption
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Higher stress levels
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Incentive condition
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Time effect
Number of subjects: 0
Study: 30663156

Group type: EXPERIMENTAL
Intervention: Diet and exercise intervention (1-h weekly diet sessions and 75-min bi-weekly physical activity sessions)
Number of subjects: 37
Study: 29746725

Group type: EXPERIMENTAL
Intervention: DS-2969b (6 mg, 20 mg, 60 mg, 200 mg, 400 mg, 600 mg)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: DS-2969b (60 mg or higher)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: DS-2969b
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 26881019

Group type: EXPERIMENTAL
Intervention: Increased urinary total polyphenol excretion (TPE)
Number of subjects: 573
Study: 25257875

Group type: EXPERIMENTAL
Intervention: Insulin (5 mU·kg(‐1)·min(‐1))
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control (standard metabolic care)
Number of subjects: 18
Study: 22157800

Group type: EXPERIMENTAL
Intervention: DVD intervention
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: Live intervention
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: Combined social contact group (DVD/live)
Number of subjects: 216

Group type: COMPARATOR
Intervention: Lecture control
Number of subjects: 216
Study: 20415595

Group type: EXPERIMENTAL
Intervention: HPV-positive glans/coronal sulcus specimens
Number of subjects: 2168

Group type: COMPARATOR
Intervention: HPV-negative glans/coronal sulcus specimens
Number of subjects: 2168
Study: 17998497

Group type: EXPERIMENTAL
Intervention: Test results management tool embedded in electronic health record
Number of subjects: 570
Study: 15127089

Group type: EXPERIMENTAL
Intervention: Vegetable juice supplementation (one can daily)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Vegetable juice supplementation
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo (orange soda, placebo pill daily)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study: 11779889

Group type: EXPERIMENTAL
Intervention: Aspirin (81 to 325 mg per day)
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Aspirin (650 mg per day)
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Aspirin (975 to 1300 mg per day)
Number of subjects: 87

Group type: COMPARATOR
Intervention: No aspirin (no antithrombotic drugs or ticlopidine)
Number of subjects: 87
Study: 9842977

Group type: EXPERIMENTAL
Intervention: Amoxicillin 500 mg x 2
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Cefadroxil 500 mg x 2
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Cefixime 200 mg
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Cefixime 200 mg with Niflumic acid (250 mg)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Cefixime 200 mg with Paracetamol (500 mg)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo capsule
Number of subjects: 6
Study: 7734464

Group type: EXPERIMENTAL
Intervention: Matrix outpatient stimulant treatment
Number of subjects: 146
Study: 2477936

Group type: EXPERIMENTAL
Intervention: Flutamide (750 mg/d)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 84
Study: 5431082

Group type: EXPERIMENTAL
Intervention: Nitrous oxide, oxygen, and halothane
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Methohexitone
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Propanidid
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Thiopentone
Number of subjects: 65
Study: 31764289

Group type: EXPERIMENTAL
Intervention: Intense Pulsed Light (IPL)
Number of subjects: 114

Group type: COMPARATOR
Intervention: Sham
Number of subjects: 114
Study: 31560137

Group type: EXPERIMENTAL
Intervention: Benazepril (0.5‐1.0 mg/kg) administered PO once daily for up to 2 years
Number of subjects: 151

Group type: COMPARATOR
Intervention: Placebo administered PO once daily for up to 2 years
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Benazepril
Number of subjects: 151

Group type: COMPARATOR
Intervention: Benazepril and Placebo
Number of subjects: 151
Study: 28599199

Group type: EXPERIMENTAL
Intervention: 1L normal saline (NS) administered as a rapid infusion over 30 min
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 1L normal saline (NS) administered as a slow infusion over 120 min
Number of subjects: 6

Group type: COMPARATOR
Intervention: Control group (baseline measurements)
Number of subjects: 6
Study: 25557740

Group type: EXPERIMENTAL
Intervention: Higher cumulative bortezomib dose (≥39 mg/m²)
Number of subjects: 340

Group type: COMPARATOR
Intervention: Lower cumulative bortezomib dose (<39 mg/m²)
Number of subjects: 340

Group type: EXPERIMENTAL
Intervention: Higher cumulative bortezomib dose (≥39 mg/m²) after landmark analysis
Number of subjects: 340

Group type: COMPARATOR
Intervention: Lower cumulative bortezomib dose (<39 mg/m²) after landmark analysis
Number of subjects: 340
Study: 23256711

Group type: EXPERIMENTAL
Intervention: Active recovery
Number of subjects: 9

Group type: COMPARATOR
Intervention: Stretching
Number of subjects: 9

Group type: COMPARATOR
Intervention: Deep massage
Number of subjects: 9

Group type: COMPARATOR
Intervention: Superficial massage
Number of subjects: 9

Group type: COMPARATOR
Intervention: Passive recovery
Number of subjects: 9
Study: 21991950

Group type: EXPERIMENTAL
Intervention: Acyclovir suppression (300 mg/m² per dose orally, three times daily for 6 months)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Acyclovir suppression
Number of subjects: 74
Study: 19863282

Group type: EXPERIMENTAL
Intervention: MDIS (metered dose inhaler with spacer device)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Standard nebulizer therapy
Number of subjects: 86
Study: 16923091

Group type: EXPERIMENTAL
Intervention: High-dose insulin treatment (short-acting insulin 1 IU/kg/h with 30% glucose 1.5 ml/kg/h)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control treatment (saline)
Number of subjects: 40

Group type: COMPARATOR
Intervention: High-dose insulin treatment and Control treatment
Number of subjects: 40
Study: 14579657

Group type: EXPERIMENTAL
Intervention: 0.05% oxymetazoline nasal spray (2 sprays, 0.1 ml/spray) 3 times daily for 4 weeks
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo nasal spray
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 0.05% oxymetazoline nasal spray
Number of subjects: 30
Study: 10893356

Group type: EXPERIMENTAL
Intervention: Chest radiographs showing cardiac enlargement
Number of subjects: 2454

Group type: EXPERIMENTAL
Intervention: Chest radiographs showing pulmonary artery enlargement
Number of subjects: 2454

Group type: EXPERIMENTAL
Intervention: Chest radiographs showing normal results
Number of subjects: 2454

Group type: EXPERIMENTAL
Intervention: Chest radiographs showing abnormal results
Number of subjects: 2454
Study: 8813270

Group type: EXPERIMENTAL
Intervention: Plasma-exchange (PE)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Sham plasma-exchange (SPE)
Number of subjects: 18
Study: 1580724

Group type: EXPERIMENTAL
Intervention: Thrombolytic therapy
Number of subjects: 4891

Group type: EXPERIMENTAL
Intervention: Coronary angiography
Number of subjects: 4891

Group type: EXPERIMENTAL
Intervention: Coronary angioplasty
Number of subjects: 4891

Group type: EXPERIMENTAL
Intervention: Bypass surgery
Number of subjects: 4891

Group type: EXPERIMENTAL
Intervention: Hospital mortality
Number of subjects: 4891

Group type: EXPERIMENTAL
Intervention: Mortality in women undergoing bypass surgery
Number of subjects: 4891
Study: 4016041

Group type: EXPERIMENTAL
Intervention: New method for assessing microhaemorrhage
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Two different general anaesthetic induction regimens
Number of subjects: 16
Study: 30831467

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: MO 12c
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: PD 12c
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: MO 12c + PD 12c
Number of subjects: 52
Study: 27830923

Group type: EXPERIMENTAL
Intervention: CTAR exercise
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Shaker exercise
Number of subjects: 90

Group type: COMPARATOR
Intervention: Routine treatments (Control group)
Number of subjects: 90
Study: 26060880

Group type: EXPERIMENTAL
Intervention: Therapeutic hypothermia (TH) titrated between 32°C and 35°C
Number of subjects: 17

Group type: COMPARATOR
Intervention: Standard care (Control)
Number of subjects: 17
Study: 25148375

Group type: EXPERIMENTAL
Intervention: Polymeric nanoparticles containing curcumin
Number of subjects: 0
Study: 21604891

Group type: EXPERIMENTAL
Intervention: Memory training intervention focusing on self-regulatory factors such as self-efficacy and active engagement.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Memory training intervention with strategy usage and strategy change as predictors.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Self-efficacy change as the main predictor of memory change for text recall.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Active engagement in training as a factor influencing memory gains.
Number of subjects: 0
Study: 19525207

Group type: EXPERIMENTAL
Intervention: Mouthpiece-based methods (desktop and portable computerized devices)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Direct observation (video recording only)
Number of subjects: 30
Study: 18163056

Group type: EXPERIMENTAL
Intervention: Klonidine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hyperbaric oxygenation therapy
Number of subjects: 0
Study: 15057855

Group type: EXPERIMENTAL
Intervention: Pulsed electromagnetic fields
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 64
Study: 11429343

Group type: EXPERIMENTAL
Intervention: 0.5% tetracaine in 7.5% glucose
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: 0.5% tetracaine in 0.75% glucose
Number of subjects: 100
Study: 9808685

Group type: EXPERIMENTAL
Intervention: Finasteride (5 mg once daily for 10 days) with 10 mg/kg tirilazad mesylate orally
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Finasteride (5 mg once daily for 10 days) with 2 mg/kg tirilazad mesylate i.v.
Number of subjects: 8
Study: 7851350

Group type: EXPERIMENTAL
Intervention: Propofol (continuous intravenous infusion starting dose 3 mg kg‐1 h‐1)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Isoflurane (starting concentration of 1%)
Number of subjects: 43
Study: 2923087

Group type: EXPERIMENTAL
Intervention: Egg white in liquid-formula meals
Number of subjects: 0

Group type: COMPARATOR
Intervention: Casein in liquid-formula meals
Number of subjects: 0

Group type: COMPARATOR
Intervention: Whey protein in liquid-formula meals
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Enzyme- or acid-hydrolyzed milk-protein products
Number of subjects: 0
Study: 1096908

Group type: EXPERIMENTAL
Intervention: Etidocaine at 10 mg/min
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Etidocaine at 20 mg/min
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lignocaine at 20 mg/min
Number of subjects: 0

Group type: COMPARATOR
Intervention: Bupivacaine
Number of subjects: 0
Study: 29781935

Group type: EXPERIMENTAL
Intervention: Balance training (8 sessions over 4 weeks, 2 times per week)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Waiting control group (no training)
Number of subjects: 14
Study: 31484377

Group type: EXPERIMENTAL
Intervention: Millet-based mid-day meals
Number of subjects: 1500

Group type: COMPARATOR
Intervention: Control group (fortified rice-based mid-day meal)
Number of subjects: 1500

Group type: EXPERIMENTAL
Intervention: Millet-based menu items
Number of subjects: 1500
Study: 28535819

Group type: EXPERIMENTAL
Intervention: Cephalexin (overt)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Ibuprofen (overt)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Paracetamol (overt)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo (covert)
Number of subjects: 50
Study: 24441732

Group type: EXPERIMENTAL
Intervention: Computer-assisted navigation systems (CANS)
Number of subjects: 214

Group type: COMPARATOR
Intervention: Conventional surgery
Number of subjects: 214
Study: 23211814

Group type: EXPERIMENTAL
Intervention: Macular pigment density
Number of subjects: 150
Study: 21730857

Group type: EXPERIMENTAL
Intervention: New hearing aid
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional hearing aid
Number of subjects: 20
Study: 19483294

Group type: EXPERIMENTAL
Intervention: Intensive insulin therapy
Number of subjects: 71

Group type: COMPARATOR
Intervention: Traditional therapy
Number of subjects: 71
Study: 16719026

Group type: EXPERIMENTAL
Intervention: Static positional stretches of the stroke‐affected shoulder twice daily and positioned the stroke‐affected upper limb in an armrest support at all other times when seated.
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group (comparison group).
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Treatment group.
Number of subjects: 32